Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry refers to the specific analgesic regimen used as the control arm in a clinical trial (NCT02684305) conducted by the Hospital General Naval de Alta Especialidad - Escuela Medico Naval. The regimen consists of a combination of three non-opioid analgesics: paracetamol (acetaminophen), metamizole (dipyrone), and ketorolac. Paracetamol and metamizole are primarily used for their analgesic and antipyretic properties, while ketorolac is a potent non-steroidal anti-inflammatory drug (NSAID) that provides significant postoperative pain relief. The combination works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of pro-inflammatory prostaglandins. This specific protocol was evaluated in pediatric patients aged 6 to 14 years undergoing surgery to compare its efficacy against laughter therapy in reducing postoperative pain, anxiety, and hospital stay duration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paracetamol + metamizole + ketorolac.